Breaking News

VWR To Acquire Peqlab Biotechnologie

By Kristin Brooks | February 3, 2014

Expands product portfolio

VWR International has entered an agreement to acquire Peqlab Biotechnologie GmbH, including its subsidiaries and operations in the U.S., UK and Austria, and manufacturing operation Clemens GmbH in Germany. The agreement is subject to customary closing conditions. Financial terms were not disclosed.
Peqlab, headquartered in Erlangen, Germany, develops, manufactures and supplies molecular and cell biology reagents, consumables and instruments to support education, research, healthcare and pharmaceutical industries.
"Peqlab is recognized in Germany and beyond as a specialist distributor of life science products, including the Peqlab brand product range," said Manuel Brocke-Benz, VWR's president and chief executive officer. "Peqlab's dedicated and specialist staff, with their focus on providing impeccable quality, will only enhance our customers' experience."
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks